Maler et al. [10] observed that CD34+ counts were negatively correlated with the levels of β-amyloid plaques (Aβ1–42) and the Aβ42/40 ratio in cerebrospinal fluid, both of which are important biomarkers in AD pathogenesis. This evidence concerns the gene CD34 and Alzheimer disease.